Core Viewpoint - Southbound funds have significantly increased their holdings in Jinxin Reproductive Medicine (01951.HK), indicating strong investor interest in the company [1] Group 1: Shareholding Changes - On December 1, southbound funds increased their holdings by 2.9025 million shares, representing a 0.20% change [2] - Over the past five trading days, there has been a cumulative net increase of 27.119 million shares held by southbound funds [1][2] - In the last 20 trading days, southbound funds have increased their holdings on 15 occasions, with a total net increase of 48.7178 million shares [1] Group 2: Current Holdings - As of now, southbound funds hold a total of 1.485 billion shares of Jinxin Reproductive Medicine, accounting for 53.83% of the company's issued ordinary shares [1][2] Group 3: Company Overview - Jinxin Reproductive Medicine is an investment holding company primarily providing in vitro fertilization (IVF) services [2] - The company offers a range of services including assisted reproductive services, management services, mobile surgical center facilities, auxiliary medical services, and sales of medical consumables and equipment, mainly in China and the United States [2]
锦欣生殖（01951.HK）：12月1日南向资金增持290.25万股